drugset / Trial / NCT02890823

Effect of Three Different Doses of Oral Cholecalciferol on 25-Hydroxyvitamin D Changes Among Epilepsy Patients With Hypovitaminosis D

NCT02890823

Phase 4 Completed 210 enrolled Chulalongkorn University
RandomizedParallel-groupDouble-blindTreatment

Summary

To characterize the effect of three different doses of vitamin D3 supplementation on serum 25-hydroxyvitamin D (25(OH)D) changes in epilepsy patients receiving enzyme-inducing antiepileptic drugs (EIAEDs) versus patients receiving non enzyme-inducing antiepileptic drugs (non-EIAEDs), and to determine the prevalence of and risk factors for hypovitaminosis D among Thai patients with epilepsy.

Timeline

Start
2015-07
Primary completion
2016-03
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 1000 iu Oral
Subject Cholecalciferol Other / unclassified 3000 iu Oral
Subject Cholecalciferol Other / unclassified 6000 iu Oral

Indications